Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis실험적 폐렴구균 수막염에서 신경 손상의 바이오마커로서 뇌척수액 및 혈액에서 신경필라멘트 경쇄 평가Research Published on 2020-10-072024-07-30 Journal: Journal of Neuroinflammation [Category] 폐렴구균 감염증, [키워드] neurofilament light chain Neuroinflammation neuronal damage pneumococcal meningitis serum biomarker [DOI] 10.1186/s12974-020-01966-3 PMC 바로가기 [Article Type] Research
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and NeuroinflammationReview Published on 2020-10-012023-07-06 Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and [Category] SARS, [키워드] angiotensin-converting enzyme 2 COVID-19 Cytokine storm Mast cells Neuroinflammation severe acute respiratory syndrome coronavirus 2 Traumatic brain injury [DOI] 10.1177/1073858420941476 [Article Type] Review
Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19Article Published on 2020-10-012023-06-16 Journal: The Australian and New Zealand Journal of Psychiatry [Category] MERS, SARS, [키워드] Anosmia Neuroinflammation neuropsychiatric complications SARS-CoV-2 vertical transmission [DOI] 10.1177/0004867420961472 PMC 바로가기
Neurological consequences of COVID-19: what have we learned and where do we go from here?Review Published on 2020-09-302022-10-30 Journal: Journal of Neuroinflammation [Category] COVID-19, SARS, [키워드] accumulating acute respiratory distress Anosmia ARDS atypical symptom caused Central nervous system Clinical management clinical study CNS Coagulopathy consequence coronavirus Coronavirus disease-19 COVID-19 COVID-19 patient COVID-19 patients Cytokine storm dry cough dysfunction Effect fatigue Fever Headaches Health Infarction lower respiratory system MERS nausea Neuroinflammation neurological neurological signs neurotropism Neutrophil extracellular traps Outbreaks pandemic pathogen Pneumonia public health reduce SARS-CoV SARS-CoV-2 SARS-CoV-2 infected patient SARS-COV-2 infection stroke syndrome target therapeutic therapy Vaccine [DOI] 10.1186/s12974-020-01957-4 PMC 바로가기 [Article Type] Review
Would Repurposing Minocycline Alleviate Neurologic Manifestations of COVID-19?Neuroscience Published on 2020-09-302022-10-31 Journal: Frontiers in Neuroscience [Category] COVID-19, [키워드] autonomic system COVID-19 hypoxia manifestation microglia Minocycline Neuroinflammation repurposing Respiratory syndrome SARS-CoV-2 [DOI] 10.3389/fnins.2020.577780 PMC 바로가기 [Article Type] Neuroscience
SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crimeReview Published on 2020-09-302022-10-28 Journal: Aging (Albany NY) [Category] COVID-19, [키워드] acute respiratory syndrome adverse outcome age aging Central nervous system characteristic chronic inflammation Chronic low-grade inflammation Combination consequence COVID-19 detrimental disease immune system immunosenescence inflammaging neurodegenerative Neuroinflammation outbreak outcome pandemic predisposition risk factor SARS-CoV-2 SARS-COV-2 infection severity viral infection virus Wuhan, China [DOI] 10.18632/aging.103989 PMC 바로가기 [Article Type] Review
Neurological Damage by Coronaviruses: A Catastrophe in the Queue!Immunology Published on 2020-09-102022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] animal model anomalies Anxiety Brain bystander catastrophe caused cellular CNS cognitive Coronaviruses Cytokine storm damage develop disease disorder dysfunction Encephalitis explain Infection Inflammation Influenza manifestation massive measles virus MERS-CoV microglial priming Neuroinflammation neurological neurological manifestation pathogenic pathology Patient peripheral Primary infection reported SARS-CoV-1 SARS-CoV-2 susceptibility syndrome viral infection virus [DOI] 10.3389/fimmu.2020.565521 PMC 바로가기 [Article Type] Immunology
COVID-19: Neurological Considerations in Neonates and ChildrenReview Published on 2020-09-102022-10-31 Journal: Children [Category] COVID-19, [키워드] age Brain children consequence Consequences coronavirus coronavirus SARS-CoV-2 COVID-19 Cytokine storm delirium develop disease disorders dysfunction Encephalopathy Headaches increasingly Infection Neonate Neonates nervous system neurodevelopment Neuroinflammation Neuroinvasive neurologic neurological Neurological involvement neurological manifestation Neuropsychiatric neurotropism pediatric SARS-CoV-2 virus with COVID-19 worldwide pandemic [DOI] 10.3390/children7090133 PMC 바로가기 [Article Type] Review
Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic ComplicationsArticle Published on 2020-09-082022-10-30 Journal: Molecular neurobiology [Category] COVID-19, MERS, SARS, [키워드] activated addition Affect affecting Aminoacridine anti-inflammatory agents Anti-inflammatory drugs antimalarial Antimalarials Aortic body arachidonic acid blood vessels Brain endothelial cells carotid body Cell culture Central nervous system Chloroquine clinical trial CNS combating Complication coronavirus coronavirus disease Coronavirus replication COVID COVID-19 COX cPLA2 cross cytokine Cytokine storm cytosolic Cytosolic phospholipase A2 Dementia disorder DMT1 drug Effect Eicosanoids ENhance expression free radical Free radical damage free radical formation generate Glossopharyngeal nerve hippocampus Hydroxychloroquine Hypoxemia impair induce Inflammation Inflammatory response inhibit inhibiting inhibition inhibitor iron accumulation Iron transport isoform isoforms lung lysosomal enzymes lysosome Lysosomes mice Microcirculation microglia Microvessels Neuroinflammation Neurovascular Nucleus of the tractus solitarius organ oxidative damage oxidative stress PLA2G2D pro-inflammatory produced quinacrine reducing Respiratory centre resulting SARS SARS-CoV SARS-CoV-2 SARS-CoV-2 virus Secretory phospholipase A2 Seizures severe cases shown silent sPLA2 IID statins stroke the SARS-CoV-2 virus tissue TNF-α Treatment unique vagus nerve Vascular vascular dementia viral replication [DOI] 10.1007/s12035-020-02093-z PMC 바로가기 [Article Type] Article
COVID-19: dealing with a potential risk factor for chronic neurological disordersReview Published on 2020-08-272022-10-29 Journal: Journal of Neurology [Category] COVID-19, MERS, SARS, [키워드] acute respiratory distress Autoimmune Central nervous system clinical evidence complex consequence COVID-19 Demyelination diagnosing disorders Encephalitis Gut headache immunopathology increasingly initiated multiple sclerosis Narcolepsy neurodegeneration neurodegenerative disorders Neuroinflammation Neurological disorder Neurological disorders neurological manifestation Parkinson’s disease Parkinson’s disease pathogenic mechanism patients with COVID-19 potential risk reported responsible risk factor Risk factors SARS-CoV2 SARS-CoV2 infection Seizures serology severe pneumonia sleepiness stroke susceptible individuals syndrome systemic inflammatory response tissue [DOI] 10.1007/s00415-020-10131-y PMC 바로가기 [Article Type] Review